dehydro-aripiprazole,
dehydroaripiprazole,
129722-25-4,
Dehydroaripiprazole,
Dehydro aripiprazole,
Dehydro-aripiprazole,
UNII-2S514OZH3B,
2S514OZH3B,
CHEMBL161792,
7-[4-[4-(2,3-DICHLOROPHENYL)-1-PIPERAZINYL]BUTOXY]-2(1H)-QUINOLINONE,
2(1H)-Quinolinone, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-,
2(1H)-Quinolinone, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-,
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-2(1H)-quinolinone,
7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-1H-quinolin-2-one,
SCHEMBL8423,
Aripiprazole Dehydro Impurity,
QUI013,
SCHEMBL12961259,
CTK8C4455,
DTXSID70156225,
CDONPRYEWWPREK-UHFFFAOYSA-N,
ZINC3775469,
5504AA,
ANW-72044,
BDBM50395554,
OPC-14857,
AKOS015912272,
API0005493,
AC-26323,
DM-14857,
DB-050468,
FT-0711634,
722D254,
C-35520,
L003824,
Q27255535,
Aripiprazole EP Impurity E; Aripiprazole USP RC G; 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-2(1H)-quinolinone,
Dehydro aripiprazole solution, 1.0 mg/mL in methanol with 5% 1 M HCl, ampule of 1 mL, certified reference material,
C23H25Cl2N3O2,
7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)quinolin-2(1H)-one,
Aripiprazole USP Related Compound G,
CS-O-07233,
CID10114519,
AJ-45570,
AN-32381,
I14-36622,
7-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy]quinolin-2(1H)-one,